reference/32363000

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32363000

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	4881
issn	1010-4283 1423-0380
issueIdentifier	4
pageRange	4873-4881
publicationName	Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
startingPage	4873
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e772875248627f4e8719220ca2ea764f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_891d5c229d4073ba4bf852accd7248ea
bibliographicCitation	Liu S, Duan X, Xu L, Ye J, Cheng Y, Liu Q, Zhang H, Zhang S, Zhu S, Li T, Liu Y. Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy. Tumour Biol. 2016 Apr;37(4):4873–81. doi: 10.1007/s13277-015-4325-y. PMID: 26526577.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a30ab00a6f7101a28d0cfbd1ae9086fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55f6ca308ca766ba4e0c34f55f517671 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeaa4a78f96db2b4ecf0ac23b2515a82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2f7bddcb5b2a4ac4d1b5452f20ab9e18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8f4ef0f5319fac6e300cc1b80bc67df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a1b517d48c0674eb37718517908efd3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb3d6f16b194f7d7dd0d7af56311c575 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_655674dab40f0561dbd88a3907f7eb76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aef6b0c1a413f9d2bb03b6283fc43093 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d850d83266eb6e5da741f8294c4ae0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eae56aad4f1f59a5d2aee86a6fd51902
date	2015-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s13277-015-4325-y https://pubmed.ncbi.nlm.nih.gov/26526577
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7341 https://portal.issn.org/resource/ISSN/1010-4283 https://portal.issn.org/resource/ISSN/1423-0380
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy
discusses	http://id.nlm.nih.gov/mesh/M0018586 http://id.nlm.nih.gov/mesh/M0291428 http://id.nlm.nih.gov/mesh/M0351340 http://id.nlm.nih.gov/mesh/M0495206 http://id.nlm.nih.gov/mesh/M000615302 http://id.nlm.nih.gov/mesh/M0018613 http://id.nlm.nih.gov/mesh/M0028048
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2064 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2735

Total number of triples: 46.